CHEK1 and lung cancer: While HR activity impairment is observed in PPP2R2A-deficient lung cancer cells 31, it may not be a major factor in CHK1 inhibitor sensitivity of HGSOC , as HR status did not influence the PPP2R2A KD-mediated CHK1 inhibitor sensitivity in our study here.